StockData
SANUWAVE Health, Inc. logo

SANUWAVE Health, Inc. (SNWV) stock

SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$1.70−0.11 (-6.08%)

Close on Nov 17, 2026Market cap $14.62MP/E –Yield –

SANUWAVE Health ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

SANUWAVE Health's ebitda for the twelve months ending Jun 30, 2026 was $2.61M, down 58.9% year over year. For fiscal 2025 it was $5.92M, up 27.7% from the year before. The highest annual figure on record is $5.92M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.92M+27.7%
FY2024Dec 31, 2024$4.64M+850.0%
FY2023Dec 31, 2023$488.00K–
FY2022Dec 31, 2022-$8.00M–
FY2021Dec 31, 2021-$12.91M–
FY2020Dec 31, 2020-$24.90M–
FY2019Dec 31, 2019-$8.72M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$29.00K-101.8%
Q1 FY2026Mar 31, 2026-$830.00K-202.5%
Q4 FY2025Dec 31, 2025$2.34M+5.1%
Q3 FY2025Sep 30, 2025$1.13M-33.4%
Q2 FY2025Jun 30, 2025$1.61M-11.8%
Q1 FY2025Mar 31, 2025$810.00K–
Q4 FY2024Dec 31, 2024$2.23M+73.3%
Q3 FY2024Sep 30, 2024$1.69M–
Q2 FY2024Jun 30, 2024$1.83M+63.4%
Q1 FY2024Mar 31, 2024-$1.16M–
Q4 FY2023Dec 31, 2023$1.29M–
Q3 FY2023Sep 30, 2023-$344.00K–
Q2 FY2023Jun 30, 2023$1.12M–
Q1 FY2023Mar 31, 2023-$1.72M–
Q4 FY2022Dec 31, 2022-$1.19M–
Q3 FY2022Sep 30, 2022-$2.30M–
Q2 FY2022Jun 30, 2022-$2.84M–
Q1 FY2022Mar 31, 2022-$1.77M–
Q4 FY2021Dec 31, 2021-$2.10M–
Q3 FY2021Sep 30, 2021-$3.14M–
Q2 FY2021Jun 30, 2021-$3.85M–
Q1 FY2021Mar 31, 2021-$4.30M–
Q4 FY2020Dec 31, 2020-$12.66M–
Q3 FY2020Sep 30, 2020-$6.04M–
Q2 FY2020Jun 30, 2020-$3.21M–
Q1 FY2020Mar 31, 2020-$2.74M–
Q4 FY2019Dec 31, 2019-$2.50M–
Q3 FY2019Sep 30, 2019-$2.36M–
Q2 FY2019Jun 30, 2019-$2.01M–

More SANUWAVE Health figures

See a number that looks wrong?